Verastem (VSTM) Assets Average (2012 - 2026)

Verastem's (VSTM) quarterly Assets Average came in at $237.1 million in Q1 2026, up 103.33% year-on-year from $116.6 million in Q1 2025, and up 12.04% quarter-over-quarter from $211.6 million in Q4 2025.

Verastem (VSTM) Assets Average (2012 - 2026) Analysis & Trends

Verastem's Assets Average history runs 15 years deep, the most recent figure standing at $237.1 million for Q1 2026.

  • On a quarterly basis, Assets Average rose 103.33% year-over-year to $237.1 million in Q1 2026; TTM through Mar 2026 was $237.1 million, a 103.33% increase from a year earlier, with the FY2025 full-year figure at $174.0 million, up 38.5% from the prior year.
  • Assets Average climbed to $237.1 million in Q1 2026 per VSTM's latest filing, from $211.6 million in the prior quarter.
  • Across five years, Assets Average topped out at $237.1 million in Q1 2026 and bottomed at $103.1 million in Q4 2022.
  • The 5-year median for Assets Average is $116.6 million (2025), against an average of $143.4 million.
  • Across the five-year window, Assets Average tumbled 36.91% in 2024 and jumped 103.33% in 2026, its largest moves.
  • Year by year, Assets Average stood at $103.1 million in 2022, then jumped by 58.08% to $162.9 million in 2023, then tumbled by 30.06% to $114.0 million in 2024, then jumped by 85.72% to $211.6 million in 2025, then rose by 12.04% to $237.1 million in 2026.
  • Per Business Quant, the three latest VSTM Assets Average figures stand at $237.1 million (Q1 2026), $211.6 million (Q4 2025), and $186.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 303.40 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 65.01 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.37 Bn
4 NuCana 279.75 Bn 279.75 Bn - 41.64 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.06 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.71 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.91 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.30 Bn
10 Verastem 166.09 Mn -31.73 Mn 15.90 Mn 237.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 237.13 Mn
Dec 31, 2025 211.65 Mn
Sep 30, 2025 186.56 Mn
Jun 30, 2025 163.98 Mn
Mar 31, 2025 116.62 Mn
Dec 31, 2024 113.96 Mn
Sep 30, 2024 116.06 Mn
Jun 30, 2024 114.64 Mn
Mar 31, 2024 136.63 Mn
Dec 31, 2023 162.94 Mn
Sep 30, 2023 183.96 Mn
Jun 30, 2023 156.32 Mn
Mar 31, 2023 107.96 Mn
Dec 31, 2022 103.07 Mn
Sep 30, 2022 105.75 Mn
Jun 30, 2022 108.28 Mn
Mar 31, 2022 112.41 Mn
Dec 31, 2021 110.27 Mn
Sep 30, 2021 117.88 Mn
Jun 30, 2021 130.40 Mn